- Home
- CXT vs CLDX Comparison
CXT vs CLDX Comparison
Compare CXT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXT | CLDX |
|---|---|---|
| Founded | 1855 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CXT | CLDX |
|---|---|---|
| Price | $50.13 | $39.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $73.00 | $46.60 |
| AVG Volume (30 Days) | 503.0K | ★ 843.8K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $3,374,900,000.00 | $12,743,000.00 |
| Revenue This Year | $5.75 | $111.39 |
| Revenue Next Year | $4.22 | $235.85 |
| P/E Ratio | $69.04 | ★ N/A |
| Revenue Growth | 6.13 | ★ 87.78 |
| 52 Week Low | $35.71 | $21.77 |
| 52 Week High | $69.00 | $45.14 |
Technical Indicators
Market Signals| Indicator | CXT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 51.05 |
| Support Level | $47.01 | $39.45 |
| Resistance Level | $53.40 | $40.30 |
| Average True Range (ATR) | 1.55 | 1.61 |
| MACD | -0.25 | -0.40 |
| Stochastic Oscillator | 35.58 | 13.36 |
Price Performance
Historical ComparisonAbout CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.